Cover Page
Cover Page | 3 Months Ended |
Apr. 01, 2023 shares | |
Entity Information [Line Items] | |
Document Type | 10-Q |
Document Quarterly Report | true |
Entity Registrant Name | KELLOGG COMPANY |
Document Period End Date | Apr. 01, 2023 |
Document Transition Report | false |
Entity File Number | 1-4171 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 38-0710690 |
Entity Address, Address Line One | One Kellogg Square |
Entity Address, Address Line Two | P.O. Box 3599 |
Entity Address, City or Town | Battle Creek |
Entity Address, State or Province | MI |
Entity Address, Postal Zip Code | 49016-3599 |
City Area Code | 269 |
Local Phone Number | 961-2000 |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Entity Filer Category | Large Accelerated Filer |
Entity Small Business | false |
Entity Emerging Growth Company | false |
Entity Shell Company | false |
Entity Common Stock, Shares Outstanding (in shares) | 342,758,421 |
Amendment Flag | false |
Document Fiscal Period Focus | Q1 |
Document Fiscal Year Focus | 2023 |
Entity Central Index Key | 0000055067 |
Current Fiscal Year End Date | --12-30 |
Common stock | |
Entity Information [Line Items] | |
Title of 12(b) Security | Common Stock, $.25 par value per share |
Trading Symbol | K |
Security Exchange Name | NYSE |
1.000% Senior Notes Due 2024 [Member] | |
Entity Information [Line Items] | |
Title of 12(b) Security | 1.000% Senior Notes due 2024 |
Trading Symbol | K 24 |
Security Exchange Name | NYSE |
1.250% Senior Notes Due 2025 [Member] | |
Entity Information [Line Items] | |
Title of 12(b) Security | 1.250% Senior Notes due 2025 |
Trading Symbol | K 25 |
Security Exchange Name | NYSE |
0.500% Senior Notes Due 2029 | |
Entity Information [Line Items] | |
Title of 12(b) Security | 0.500% Senior Notes due 2029 |
Trading Symbol | K 29 |
Security Exchange Name | NYSE |
Consolidated Balance Sheet
Consolidated Balance Sheet - USD ($) $ in Millions | Apr. 01, 2023 | Dec. 31, 2022 |
Current assets | ||
Cash and cash equivalents | $ 347 | $ 299 |
Accounts receivable, net | 1,820 | 1,736 |
Inventories | 1,801 | 1,768 |
Other current assets | 356 | 383 |
Total current assets | 4,324 | 4,186 |
Property, net | 3,786 | 3,789 |
Operating lease right-of-use assets | 611 | 617 |
Goodwill | 5,690 | 5,686 |
Other intangibles, net | 2,297 | 2,296 |
Investments in unconsolidated entities | 434 | 432 |
Other assets | 1,488 | 1,490 |
Total assets | 18,630 | 18,496 |
Current liabilities | ||
Current maturities of long-term debt | 567 | 780 |
Notes payable | 471 | 467 |
Accounts payable | 2,900 | 2,973 |
Current operating lease liabilities | 113 | 121 |
Accrued advertising and promotion | 813 | 766 |
Accrued salaries and wages | 214 | 370 |
Other current liabilities | 923 | 872 |
Total current liabilities | 6,001 | 6,349 |
Long-term debt | 5,759 | 5,317 |
Operating lease liabilities | 477 | 486 |
Deferred income taxes | 728 | 760 |
Pension liability | 711 | 709 |
Other liabilities | 475 | 500 |
Commitments and contingencies | ||
Equity | ||
Common stock, $.25 par value | 105 | 105 |
Capital in excess of par value | 1,033 | 1,068 |
Retained earnings | 9,293 | 9,197 |
Treasury stock, at cost | (4,666) | (4,721) |
Accumulated other comprehensive income (loss) | (1,713) | (1,708) |
Total Kellogg Company equity | 4,052 | 3,941 |
Noncontrolling interests | 427 | 434 |
Total equity | 4,479 | 4,375 |
Total liabilities and equity | $ 18,630 | $ 18,496 |
Consolidated Balance Sheet (Par
Consolidated Balance Sheet (Parenthetical) - $ / shares | Apr. 01, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Common stock, par value (in dollars per share) | $ 0.25 | $ 0.25 |
Consolidated Statement of Incom
Consolidated Statement of Income (unaudited) - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | |
Income Statement [Abstract] | ||
Net sales | $ 4,053 | $ 3,672 |
Cost of goods sold | 2,843 | 2,513 |
Selling, general and administrative expense | 770 | 642 |
Operating profit | 440 | 517 |
Interest expense | 80 | 56 |
Other income (expense), net | 26 | 74 |
Income before income taxes | 386 | 535 |
Income tax expense (benefit) | 86 | 112 |
Earnings (loss) from unconsolidated entities | 2 | 1 |
Net income | 302 | 424 |
Net income attributable to noncontrolling interests | 4 | 2 |
Net income attributable to Kellogg Company | $ 298 | $ 422 |
Per share amounts: | ||
Basic earnings (in dollars per share) | $ 0.87 | $ 1.24 |
Diluted earnings (in dollars per share) | $ 0.86 | $ 1.23 |
Average shares outstanding: | ||
Basic (in shares) | 342,000 | 340,000 |
Diluted (in shares) | 345,000 | 342,000 |
Actual shares outstanding at period end (in shares) | 343,000 | 338,000 |
Consolidated Statement of Compr
Consolidated Statement of Comprehensive Income (unaudited) - USD ($) $ in Millions | 3 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 302 | $ 424 |
Other comprehensive income (loss), pre-tax: | ||
Foreign currency translation adjustments, pre-tax | 42 | (17) |
Net investment hedges, pre-tax | ||
Net investment hedge gain (loss), pre-tax | (57) | 101 |
Cash flow hedges, pre-tax: | ||
Net deferred gain (loss) on cash flow hedges, pre-tax | (18) | 77 |
Reclassification to net income, pre-tax | 3 | 4 |
Postretirement and postemployment benefits reclassification to net income, pre-tax: | ||
Net experience (gain) loss | (1) | (1) |
Available-for-sale securities, pre-tax | ||
Unrealized gain (loss) on available-for-sale securities, pre-tax | 1 | (3) |
Other comprehensive income (loss), pre-tax | (30) | 161 |
Other comprehensive income (loss), tax (expense) benefit | ||
Foreign currency translation adjustments, tax (expense) benefit | 3 | 1 |
Net investment hedges, tax (expense) benefit | ||
Net investment hedge gain (loss), tax (expense) benefit | 15 | (27) |
Cash flow hedges, tax (expense) benefit: | ||
Net deferred gain (loss) on cash flow hedges, tax (expense) benefit | 5 | (20) |
Reclassification to net income, tax (expense) benefit | (1) | (1) |
Postretirement and postemployment benefits reclassification to net income, tax (expense) benefit: | ||
Net experience loss, tax (expense) benefit | 0 | 0 |
Available-for-sale securities, tax (expense) benefit | ||
Unrealized gain (loss) on available-for-sale securities, tax (expense) benefit | 0 | 0 |
Other comprehensive income (loss), tax (expense) benefit | 22 | (47) |
Other comprehensive income (loss), after tax: | ||
Foreign currency translation adjustments, after-tax | 45 | (16) |
Net investment hedges, after tax | ||
Net investment hedge gain (loss), after-tax | (42) | 74 |
Cash flow hedges, after tax | ||
Net deferred gain (loss) on cash flow hedges | (13) | 57 |
Reclassification to net income, after tax | 2 | 3 |
Postretirement and postemployment benefits reclassification to net income, after-tax: | ||
Net experience (gain) loss, after-tax | (1) | (1) |
Available-for-sale securities, after tax | ||
Unrealized gain (loss) on available-for-sale securities, after-tax | 1 | (3) |
Other comprehensive income (loss) | (8) | 114 |
Comprehensive income | 294 | 538 |
Net income attributable to noncontrolling interests | 4 | 2 |
Other comprehensive income (loss) attributable to noncontrolling interests | (3) | 4 |
Comprehensive income attributable to Kellogg Company | $ 293 | $ 532 |
Consolidated Statement of Equit
Consolidated Statement of Equity (unaudited) - USD ($) shares in Millions, $ in Millions | Total | Common stock | Capital in excess of par value | Retained earnings | Treasury stock | Accumulated other comprehensive income (loss) | Total Kellogg Company equity | Non-controlling interests |
Balance (in shares) at Jan. 01, 2022 | 421 | 80 | ||||||
Balance at Jan. 01, 2022 | $ 105 | $ 1,023 | $ 9,028 | $ (4,715) | $ (1,721) | $ 3,720 | $ 495 | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jan. 01, 2022 | $ 4,215 | |||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Common stock repurchased | (300) | $ (300) | (300) | |||||
Common stock repurchased (in shares) | 5 | |||||||
Net income | 424 | 422 | 422 | 2 | ||||
Dividends, Common Stock | (197) | (197) | (197) | |||||
Distributions to noncontrolling interest | (1) | 0 | (1) | |||||
Other comprehensive income (loss) | 114 | 110 | 110 | 4 | ||||
Stock compensation | 16 | 16 | 16 | |||||
Stock options exercised, issuance of other stock awards and other | 24 | (46) | 1 | $ 69 | 24 | |||
Stock options exercised and other (in shares) | (2) | |||||||
Balance (in shares) at Apr. 02, 2022 | 421 | 83 | ||||||
Balance at Apr. 02, 2022 | $ 105 | 993 | 9,254 | $ (4,946) | (1,611) | 3,795 | 500 | |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Apr. 02, 2022 | $ 4,295 | |||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Dividends declared - per share | $ 0.58 | |||||||
Balance (in shares) at Dec. 31, 2022 | 421 | 79 | ||||||
Balance at Dec. 31, 2022 | $ 3,941 | $ 105 | 1,068 | 9,197 | $ (4,721) | (1,708) | 3,941 | 434 |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2022 | 4,375 | |||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net income | 302 | 298 | 298 | 4 | ||||
Dividends, Common Stock | (202) | (202) | (202) | |||||
Distributions to noncontrolling interest | (8) | 0 | (8) | |||||
Other comprehensive income (loss) | (8) | (5) | (5) | (3) | ||||
Stock compensation | 22 | 22 | 22 | |||||
Stock options exercised, issuance of other stock awards and other | (2) | (57) | 0 | $ 55 | (2) | |||
Stock options exercised and other (in shares) | (1) | |||||||
Balance (in shares) at Apr. 01, 2023 | 421 | 78 | ||||||
Balance at Apr. 01, 2023 | 4,052 | $ 105 | $ 1,033 | $ 9,293 | $ (4,666) | $ (1,713) | $ 4,052 | $ 427 |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest at Apr. 01, 2023 | $ 4,479 | |||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Dividends declared - per share | $ 0.59 |
Consolidated Statement of Equ_2
Consolidated Statement of Equity Consolidated Statement of Equity (unaudited) (Parenthetical) - $ / shares | 3 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | |
Statement of Stockholders' Equity [Abstract] | ||
Dividends declared - per share | $ 0.59 | $ 0.58 |
Consolidated Statement of Cash
Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Millions | 3 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | |
Operating activities | ||
Net income | $ 302 | $ 424 |
Adjustments to reconcile net income to operating cash flows: | ||
Depreciation and amortization | 116 | 119 |
Postretirement benefit plan expense (benefit) | (15) | (73) |
Deferred income taxes | (6) | 42 |
Stock compensation | 22 | 16 |
Other | (10) | 28 |
Postretirement benefit plan contributions | (5) | (7) |
Changes in operating assets and liabilities, net of acquisitions: | ||
Trade receivables | (110) | (184) |
Inventories | (27) | (160) |
Accounts payable | 9 | 207 |
All other current assets and liabilities | 0 | (85) |
Net cash provided by (used in) operating activities | 276 | 327 |
Investing activities | ||
Additions to properties | (203) | (138) |
Issuance of notes receivable | (5) | 0 |
Purchases of available for sale securities | (5) | (2) |
Sales of available for sale securities | 5 | 1 |
Settlement of net investment hedges | 17 | 37 |
Collateral paid on derivatives | (15) | (13) |
Other | 1 | 3 |
Net cash provided by (used in) investing activities | (205) | (112) |
Financing activities | ||
Net issuances (reductions) of notes payable | 3 | 313 |
Issuances of long-term debt | 401 | 0 |
Reductions of long-term debt | (216) | (25) |
Net issuances of common stock | 19 | 40 |
Common stock repurchases | 0 | (300) |
Cash dividends | (202) | (197) |
Other | (38) | (2) |
Net cash provided by (used in) financing activities | (33) | (171) |
Effect of exchange rate changes on cash and cash equivalents | 10 | (17) |
Increase (decrease) in cash and cash equivalents | 48 | 27 |
Cash and cash equivalents at beginning of period | 299 | 286 |
Cash and cash equivalents at end of period | 347 | 313 |
Supplemental cash flow disclosures of non-cash investing activities | ||
Additions to properties included in accounts payable | $ 105 | $ 90 |
Accounting Policies
Accounting Policies | 3 Months Ended |
Apr. 01, 2023 | |
Accounting Policies [Abstract] | |
Accounting Policies | Accounting policies Basis of presentation The unaudited interim financial information of Kellogg Company (the Company) included in this report reflects all adjustments, all of which are of a normal and recurring nature, that management believes are necessary for a fair statement of the results of operations, comprehensive income, financial position, equity and cash flows for the periods presented. This interim information should be read in conjunction with the financial statements and accompanying footnotes within the Company’s 2022 Annual Report on Form 10-K. The condensed balance sheet information at December 31, 2022 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. The results of operations for the quarter ended April 1, 2023 are not necessarily indicative of the results to be expected for other interim periods or the full year. Accounts payable - Supplier Finance Programs The Company establishes competitive market-based terms with our suppliers, regardless of whether they participate in supplier finance programs, which generally range from 0 to 150 days dependent on their respective industry and geography. The Company has agreements with third parties to provide accounts payable tracking systems which facilitate participating suppliers’ ability to monitor and, if elected, sell payment obligations from the Company to designated third-party financial institutions. Participating suppliers may, at their sole discretion, make offers to sell one or more payment obligations of the Company prior to their scheduled due dates at a discounted price to participating financial institutions. The Company has no economic interest in the sale of these suppliers’ receivables and no direct financial relationship with the financial institutions concerning these services. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to sell amounts under the arrangements. However, the Company’s right to offset balances due from suppliers against payment obligations is restricted by the agreements for those payment obligations that have been sold by suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Consolidated Statement of Cash Flows. As of April 1, 2023, $1.1 billion of the Company’s outstanding payment obligations had been placed in the accounts payable tracking system. As of December 31, 2022, $1.1 billion of the Company’s outstanding payment obligations had been placed in the accounts payable tracking system. Accounting standards adopted in the period Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations. In September 2022, the FASB issued an ASU to improve the disclosures of supplier finance programs. Specifically, the ASU requires disclosure of key terms of the supplier finance programs and a rollforward of the related obligations. The amendments in this ASU do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company has historically presented information regarding the nature and amount of outstanding Accounts Payable obligations confirmed into supplier finance programs within the Accounting Policies note of the financial statements. The Company adopted the ASU in the first quarter of 2023 and plans to include the rollforward information in the first quarter of 2024. |
Proposed separation transaction
Proposed separation transaction | 3 Months Ended |
Apr. 01, 2023 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Proposed separation transaction | Proposed separation transaction During 2022, the Company announced its intent to separate its North American cereal business, via tax-free spin-off, with a target to complete the transaction during the fourth quarter of 2023, resulting in two independent public companies, each better positioned to unlock their full standalone potential. The transaction will follow the satisfaction of customary conditions, including reviews and final approval by Kellogg’s Board of Directors, receipt of an Internal Revenue Service ruling and relevant tax opinions with respect to the tax-free nature of the transaction, effectiveness of appropriate filings with the U.S. Securities and Exchange Commission, and the completion of audited financials of the new independent company. We cannot assure that the North American cereal transaction will be completed on the anticipated timeline or at all or that the terms of the separation will not change. The Company incurred pre-tax charges related to the proposed separation of $51 million for the quarter ended April 1, 2023, including $4 million in COGS and $47 million in SGA expense. These charges were primarily related to legal and consulting costs. |
Sale of Accounts Receivable
Sale of Accounts Receivable | 3 Months Ended |
Apr. 01, 2023 | |
Transfers and Servicing of Financial Assets [Abstract] | |
Sale of accounts receivable | Sale of accounts receivable The Company has a program in which a discrete group of customers are allowed to extend their payment terms in exchange for the elimination of early payment discounts (Extended Terms Program). The Company has two Receivable Sales Agreements (Monetization Programs) described below, which are intended to directly offset the impact the Extended Terms Program would have on the days-sales-outstanding (DSO) metric that is critical to the effective management of the Company's accounts receivable balance and overall working capital. The Monetization Programs sell, on a revolving basis, certain trade accounts receivable invoices to third party financial institutions. Transfers under these agreements are accounted for as sales of receivables resulting in the receivables being de-recognized from the Consolidated Balance Sheet. The Monetization Programs provide for the continuing sale of certain receivables on a revolving basis until terminated by either party; however the maximum receivables that may be sold at any time is approximately $945 million. During 2023 the Company amended the agreements to increase the previous maximum receivables sold limit from approximately $920 million as of December 31, 2022. The Company has no retained interest in the receivables sold, however the Company does have collection and administrative responsibilities for the sold receivables. The Company has not recorded any servicing assets or liabilities as of April 1, 2023 and December 31, 2022 for these agreements as the fair value of these servicing arrangements as well as the fees earned were not material to the financial statements. Accounts receivable sold of $911 million and $865 million remained outstanding under these arrangements as of April 1, 2023 and December 31, 2022, respectively. The proceeds from these sales of receivables are included in cash from operating activities in the Consolidated Statement of Cash Flows in the period of sale. The recorded net loss on sale of receivables was $12 million and $2 million for the quarters ended April 1, 2023 and April 2, 2022 , . The recorded loss is included in Other income and expense, net (OIE). Other programs |
Divestiture
Divestiture | 3 Months Ended |
Apr. 01, 2023 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Divestiture | Divestiture Russia In December 2022 the Company entered into an agreement to sell our Russian business to a third party, pending a number of local government regulatory approvals. The business is a part of our Europe reportable segment. The pending sale includes the entirety of the Company’s operations in Russia and will result in a complete exit from the market. Although the Company has entered into a definitive agreement to sell its Russian business, there is no assurance that we will obtain the necessary regulatory approvals or that the other terms and conditions to complete the sale will be satisfied or approved. As of April 1, 2023 the pending sale did not meet the criteria for held for sale accounting due to uncertainty related to the evolving regulatory approvals that are required in order to complete the transaction. If approved, the Company expects to incur a loss on the transaction due to the release of historical foreign currency translation adjustments (CTA). The net book value of the assets related to the Russian business was $70 million, which are expected to be recoverable on a held and used basis, and historical CTA losses was $95 million. The net value of assets and CTA losses collectively represent less than 1% of total Company assets as of April 1, 2023. The Kellogg business in Russia represents approximately 1% of consolidated Kellogg Company net sales. |
Equity
Equity | 3 Months Ended |
Apr. 01, 2023 | |
Equity [Abstract] | |
Equity | Equity Earnings per share Basic earnings per share is determined by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is similarly determined, except that the denominator is increased to include the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued. Dilutive potential common shares consist principally of employee stock options issued by the Company, restricted stock units, and certain contingently issuable performance shares. There were approximately 4 million and 8 million anti-dilutive potential common shares excluded from the calculation for the quarters ended April 1, 2023 and April 2, 2022, respectively. Please refer to the Consolidated Statement of Income for basic and diluted earnings per share for the quarters ended April 1, 2023 and April 2, 2022. Share repurchases In December 2022, the Board of Directors approved an authorization to repurchase up to $1.5 billion of our common stock through December 2025. During the quarter ended April 1, 2023, the Company did not repurchase any shares of common stock . D uring the quarter ended April 2, 2022, the Company repurchased approximately 5 million shares of common stock for a total of $300 million. Comprehensive income Comprehensive income includes net income and all other changes in equity during a period except those resulting from investments by or distributions to shareholders. Other comprehensive income consists of foreign currency translation adjustments, fair value adjustments associated with cash flow hedges, which are recorded in interest expense within the statement of income, upon reclassification from Accumulated Other Comprehensive Income (AOCI), adjustments for net experience gains (losses), prior service credit (costs) related to employee benefit plans and adjustments for unrealized (gains) losses on available-for-sale securities, which are recorded in other income (expense) within the statement of income, upon reclassification from AOCI. The related tax effects of these items are recorded in income tax expense within the statement of income, upon reclassification from AOCI. Accumulated other comprehensive income (loss), net of tax, as of April 1, 2023 and December 31, 2022 consisted of the following: (millions) April 1, December 31, Foreign currency translation adjustments $ (2,063) $ (2,111) Net investment hedges gain (loss) 240 282 Cash flow hedges — net deferred gain (loss) 139 150 Postretirement and postemployment benefits: Net experience gain (loss) 1 2 Prior service credit (cost) (27) (27) Available-for-sale securities unrealized net gain (loss) (3) (4) Total accumulated other comprehensive income (loss) $ (1,713) $ (1,708) |
Long-term debt
Long-term debt | 3 Months Ended |
Apr. 01, 2023 | |
Debt Disclosure [Abstract] | |
Long-term debt | Long-term debt During the first quarter of 2023, the Company issued $400 million of ten-year 5.25% Notes due 2033, resulting in net proceeds after discount and underwriting commissions of $396 million. The proceeds from these notes were used for general corporate purposes, including the payment of offering related fees and expenses, repayment of the $210 million 2.75% Notes when they matured on March 1, 2023, and repayment of a portion of commercial paper borrowings. The Notes contain customary covenants that limit the ability of the Company and its restricted subsidiaries (as defined) to incur certain liens or enter into certain sale and lease-back transactions, as well as a change of control provision. In connection with the debt issuance, the Company terminated forward starting interest rate swaps with notional amounts totaling $400 million, resulting in a gain of $47 million in the first quarter of 2023. These derivatives were accounted for as cash flow hedges. The total net gain of $91 million, including those realized in prior periods, were recorded in accumulated other comprehensive income and will be amortized to interest expense over the term of the Notes. The effective interest rate on the Notes, reflecting issuance discount and hedge settlement is 3.06% at April 1, 2023. |
Employee Benefits
Employee Benefits | 3 Months Ended |
Apr. 01, 2023 | |
Retirement Benefits [Abstract] | |
Employee Benefits | Employee benefits The Company sponsors a number of U.S. and foreign pension plans as well as other nonpension postretirement and postemployment plans to provide various benefits for its employees. These plans are described within the footnotes to the Consolidated Financial Statements included in the Company’s 2022 Annual Report on Form 10-K. Components of Company benefit plan (income) expense for the periods presented are included in the tables below. Excluding the service cost component, these amounts are included within Other income (expense) in the Consolidated Statement of Income. Pension Quarter ended (millions) April 1, 2023 April 2, 2022 Service cost $ 6 $ 9 Interest cost 44 29 Expected return on plan assets (53) (71) Amortization of unrecognized prior service cost 2 2 Recognized net gain — (21) Total pension income $ (1) $ (52) Other nonpension postretirement Quarter ended (millions) April 1, 2023 April 2, 2022 Service cost $ 2 $ 3 Interest cost 10 6 Expected return on plan assets (24) (28) Amortization of unrecognized prior service cost (2) (2) Total postretirement benefit income $ (14) $ (21) Postemployment Quarter ended (millions) April 1, 2023 April 2, 2022 Service cost $ 1 $ 1 Recognized net experience gain (1) (1) Total postemployment expense $ — $ — For the quarter ended April 2, 2022, the Company recognized a gain of $21 million related to the remeasurement of two U.S. pension plans. These remeasurements were the result of distributions that exceeded service and interest costs resulting in settlement accounting for those specific plans. The remeasurements recognized were due primarily to an increase in the discount rate relative to the previous remeasurement date partially offset by lower than expected return on plan assets. Company contributions to employee benefit plans are summarized as follows: (millions) Pension Nonpension postretirement Total Quarter ended: April 1, 2023 $ — $ 5 $ 5 April 2, 2022 $ 1 $ 6 $ 7 Full year: Fiscal year 2023 (projected) $ 5 $ 21 $ 26 Fiscal year 2022 (actual) $ 3 $ 20 $ 23 Plan funding strategies may be modified in response to management's evaluation of tax deductibility, market conditions, and competing investment alternatives. |
Income Taxes
Income Taxes | 3 Months Ended |
Apr. 01, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income taxes The consolidated effective tax rate for the quarters ended April 1, 2023 and April 2, 2022 was 22% and 21%, respectively. As of April 1, 2023, the Company classifie d $21 million of unr ecognized tax benefits as a net current tax liability. Management's estimate of reasonably possible changes in unrecognized tax benefits during the next twelve months consists of the current liability expected to be settled within one year, offset by appr oximately $3 million o f projected additions related primarily to ongoing intercompany transfer pricing activity. Management is currently unaware of any issues under review that could result in significant additional payments, accruals or other material deviation in this estimate. The Company’s total gross unrecognized tax benefits as of April 1, 2023 w as $37 million. Of this balance, $30 million represents the amount that, if recognized, would affect the Company’s effective income tax rate in future periods. |
Derivative Instruments and Fair
Derivative Instruments and Fair Value Measurements | 3 Months Ended |
Apr. 01, 2023 | |
Derivative Instruments and Fair Value Measurements [Abstract] | |
Derivative Instruments and Fair Value Measurements | Derivative instruments and fair value measurements The Company is exposed to certain market risks such as changes in interest rates, foreign currency exchange rates, and commodity prices, which exist as a part of its ongoing business operations. Management uses derivative and nonderivative financial instruments and commodity instruments, including futures, options, and swaps, where appropriate, to manage these risks. Instruments used as hedges must be effective at reducing the risk associated with the exposure being hedged. The Company designates derivatives and nonderivative hedging instruments as cash flow hedges, fair value hedges, net investment hedges, and uses other contracts to reduce volatility in interest rates, foreign currency and commodities. As a matter of policy, the Company does not engage in trading or speculative hedging transactions. Derivative instruments are classified on the Consolidated Balance Sheet based on the contractual maturity of the instrument or the timing of the underlying cash flows of the instrument for derivatives with contractual maturities beyond one year. Any collateral associated with derivative instruments is classified as other assets or other current liabilities on the Consolidated Balance Sheet depending on whether the counterparty collateral is in an asset or liability position. Margin deposits related to exchange-traded commodities are recorded in accounts receivable, net on the Consolidated Balance Sheet. On the Consolidated Statement of Cash Flows, cash flows associated with derivative instruments are classified according to the nature of the underlying hedged item. Cash flows associated with collateral and margin deposits on exchange-traded commodities are classified as investing cash flows when the collateral account is in an asset position and as financing cash flows when the collateral account is in a liability position. Total notional amounts of the Company’s derivative instruments as of April 1, 2023 and December 31, 2022 were as follows: (millions) April 1, December 31, Foreign currency exchange contracts $ 2,957 $ 2,502 Cross-currency contracts 2,101 1,983 Interest rate contracts 2,275 2,657 Commodity contracts 456 230 Total $ 7,789 $ 7,372 Following is a description of each category in the fair value hierarchy and the financial assets and liabilities of the Company that were included in each category at April 1, 2023 and December 31, 2022, measured on a recurring basis. Level 1 – Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market. For the Company, level 1 financial assets and liabilities consist primarily of commodity derivative contracts. Level 2 – Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. For the Company, level 2 financial assets and liabilities consist of interest rate swaps, cross-currency swaps and over-the-counter commodity and currency contracts. The Company’s calculation of the fair value of interest rate swaps is derived from a discounted cash flow analysis based on the terms of the contract and the interest rate curve. Over-the-counter commodity derivatives are valued using an income approach based on the commodity index prices less the contract rate multiplied by the notional amount. Foreign currency contracts are valued using an income approach based on forward rates less the contract rate multiplied by the notional amount. Cross-currency contracts are valued based on changes in the spot rate at the time of valuation compared to the spot rate at the time of execution, as well as the change in the interest differential between the two currencies. The Company’s calculation of the fair value of level 2 financial assets and liabilities takes into consideration the risk of nonperformance, including counterparty credit risk. Level 3 – Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company did not have any level 3 financial assets or liabilities as of April 1, 2023 or December 31, 2022. The following table presents assets and liabilities that were measured at fair value in the Consolidated Balance Sheet on a recurring basis as of April 1, 2023 and December 31, 2022: Derivatives designated as hedging instruments April 1, 2023 December 31, 2022 (millions) Level 1 Level 2 Total Level 1 Level 2 Total Assets: Cross-currency contracts: Other current assets $ — $ 63 $ 63 $ — $ 88 $ 88 Other assets — 26 26 — 36 36 Interest rate contracts: Other current assets — — — — 45 45 Other assets — 10 10 — 25 25 Total assets $ — $ 99 $ 99 $ — $ 194 $ 194 Liabilities: Cross-currency contracts: Other current liabilities $ — $ (7) $ (7) $ — $ — $ — Other liabilities — — — — — — Interest rate contracts(a): Other current liabilities — — — — — — Other liabilities — (77) (77) — (86) (86) Total liabilities $ — $ (84) $ (84) $ — $ (86) $ (86) (a) The fair value of the related hedged portion of the Company's long-term debt, a level 2 liability, was $1.1 billion as of April 1, 2023 and December 31, 2022, respectively. Derivatives not designated as hedging instruments April 1, 2023 December 31, 2022 (millions) Level 1 Level 2 Total Level 1 Level 2 Total Assets: Foreign currency exchange contracts: Other current assets $ — $ 58 $ 58 $ — $ 74 $ 74 Other assets — 14 14 — 14 14 Interest rate contracts: Other current assets — 9 9 — 4 4 Other assets — 6 6 — 14 14 Commodity contracts: Other current assets 6 — 6 4 — 4 Total assets $ 6 $ 87 $ 93 $ 4 $ 106 $ 110 Liabilities: Foreign currency exchange contracts: Other current liabilities $ — $ (45) $ (45) $ — $ (50) $ (50) Other liabilities — (11) (11) — (9) (9) Interest rate contracts: Other current liabilities — (11) (11) — (7) (7) Other liabilities — (9) (9) — (18) (18) Commodity contracts: Other current liabilities (6) — (6) (2) — (2) Total liabilities $ (6) $ (76) $ (82) $ (2) $ (84) $ (86) The Company has designated its outstanding foreign currency denominated debt as a net investment hedge of a portion of the Company’s investment in its subsidiaries’ foreign currency denominated net assets. The carrying value of this debt, including current and long-term, was approximately $1.6 billion as of April 1, 2023 and December 31, 2022, respectively. The following amounts were recorded on the Consolidated Balance Sheet related to cumulative basis adjustments for existing fair value hedges as of April 1, 2023 and December 31, 2022. (millions) Line Item in the Consolidated Balance Sheet in which the hedged item is included Carrying amount of the hedged liabilities Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged liabilities (a) April 1, December 31, April 1, December 31, Interest rate contracts Current maturities of long-term debt $ 273 $ 483 $ (2) $ (3) Interest rate contracts Long-term debt $ 2,288 $ 2,250 $ (63) $ (74) (a) The fair value adjustment related to current maturities of long-term debt includes ($2) million and ($3) million from discontinued hedging relationships as of April 1, 2023 and December 31, 2022, respectively. The fair value adjustment related to long-term debt includes $11 million and $13 million from discontinued hedging relationships as of April 1, 2023 and December 31, 2022, respectively. The Company has elected to not offset the fair values of derivative assets and liabilities executed with the same counterparty that are generally subject to enforceable netting agreements. However, if the Company were to offset and record the asset and liability balances of derivatives on a net basis, the amounts presented in the Consolidated Balance Sheet as of April 1, 2023 and December 31, 2022 would be adjusted as detailed in the following table: As of April 1, 2023: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 192 $ (135) $ (1) $ 56 Total liability derivatives $ (166) $ 135 $ 31 $ — As of December 31, 2022: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 304 $ (153) $ (33) $ 118 Total liability derivatives $ (172) $ 153 $ 19 $ — During the quarters ended April 1, 2023 and April 2, 2022, the Company settled certain interest rate contracts resulting in a net realized gain of approximately $47 million and $82 million, respectively. These derivatives were accounted for as cash flow hedges and the related net gains were recorded in accumulated other comprehensive income and will be amortized to interest expense over the term of the related forecasted fixed rate debt, once issued. During the quarters ended April 1, 2023 and April 2, 2022, the Company settled certain cross currency swaps resulting in a net realized gain of approximately $17 million and $37 million, respectively. T hese cross currency swaps were accounted for as net investment hedges and the related net gain was recorded in accumulated other comprehensive income. The effect of derivative instruments on the Consolidated Statements of Income and Comprehensive Income for the quarters ended April 1, 2023 and April 2, 2022 was as follows: Derivatives and non-derivatives in net investment hedging relationships (millions) Gain (loss) Gain (loss) excluded from assessment of hedge effectiveness Location of gain (loss) in income of excluded component April 1, April 2, April 1, April 2, Foreign currency denominated long-term debt $ (32) $ 68 $ — $ — Cross-currency contracts (25) 33 14 6 Interest expense Total $ (57) $ 101 $ 14 $ 6 Derivatives not designated as hedging instruments (millions) Location of gain Gain (loss) April 1, April 2, Foreign currency exchange contracts COGS $ (6) $ (12) Foreign currency exchange contracts Other income (expense), net (4) (2) Foreign currency exchange contracts SG&A (2) 1 Interest rate contracts Interest expense — 1 Commodity contracts COGS (39) 112 Total $ (51) $ 100 The effect of fair value and cash flow hedge accounting on the Consolidated Income Statement for the quarters ended April 1, 2023 and April 2, 2022: April 1, 2023 April 2, 2022 (millions) Interest Expense Interest Expense Total amounts of income and expense line items presented in the Consolidated Income Statement in which the effects of fair value or cash flow hedges are recorded $ 80 $ 56 Gain (loss) on fair value hedging relationships: Interest contracts: Hedged items (12) 41 Derivatives designated as hedging instruments 13 (40) Gain (loss) on cash flow hedging relationships: Interest contracts: Amount of gain (loss) reclassified from AOCI into income (3) (4) During the next 12 months, the Company expects $10 million of net deferred losses reported in AOCI at April 1, 2023 to be reclassified to income, assuming market rates remain constant through contract maturities. Certain of the Company’s derivative instruments contain provisions requiring the Company to post collateral on those derivative instruments that are in a liability position if the Company’s credit rating is at or below BB+ (S&P), or Baa1 (Moody’s). The fair value of all derivative instruments with credit-risk-related contingent features in a liability position on April 1, 2023 was not material. In addition, certain derivative instruments contain provisions that would be triggered in the event the Company defaults on its debt agreements. There were no collateral posting requirements as of April 1, 2023 triggered by credit-risk-related contingent features. Other fair value measurements Available for sale securities April 1, 2023 December 31, 2022 Unrealized Unrealized (millions) Cost Gain (Loss) Market Value Cost Gain (Loss) Market Value Corporate bonds $ 52 $ (4) $ 48 $ 52 $ (5) $ 47 During the quarter ended April 1, 2023, the Company sold approximately $5 million of investments in level 2 corporate bonds. The resulting gain was immaterial and recorded in Other income and (expense). Also during the quarter ended April 1, 2023, the Company purchased approximately $5 million in level 2 corporate bonds. During the quarter ended April 2, 2022, the Company sold level 2 corporate bonds for approximately $1 million resulting in an immaterial gain recorded in Other income and (expense). Also during the quarter ended April 2, 2022, the Company purchased approximately $2 million in level 2 corporate bonds. The market values of the Company's investments in level 2 corporate bonds are based on matrices or models from pricing vendors. Unrealized gains and losses are included in the Consolidated Statement of Comprehensive Income. Additionally, these investments are recorded within Other current assets and Other assets on the Consolidated Balance Sheet, based on the maturity of the individual security. The maturity dates of the securities range from 2024 to 2036. The Company reviews its investment portfolio for any unrealized losses that would be deemed other-than-temporary and requires the recognition of an impairment loss in earnings. If the cost of an investment exceeds its fair value, the Company evaluates, among other factors, general market conditions, the duration and extent to which the fair value is less than its cost, the Company's intent to hold the investment, and whether it is more likely than not that the Company will be required to sell the investment before recovery of the cost basis. The Company also considers the type of security, related industry and sector performance, and published investment ratings. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded and a new cost basis in the investment is established. If conditions within individual markets, industry segments, or macro-economic environments deteriorate, the Company could incur future impairments. Equity investments We hold equity investments in certain companies that we do not have the ability to exercise significant influence. Equity investments without a readily determinable fair value are recorded at original cost. Investments with a readily determinable fair value, which are level 2 investments, are measured at fair value based on observable market price changes, with gains and losses recorded through net earnings. Equity investments were approximately $40 million as of April 1, 2023 and December 31, 2022. Additionally, these investments were recorded within Other noncurrent assets on the Consolidated Balance Sheet. Financial instruments The carrying values of the Company’s short-term items, including cash, cash equivalents, accounts receivable, accounts payable, notes payable and current maturities of long-term debt approximate fair value. The fair value of the Company’s long-term debt, which are level 2 liabilities, is calculated based on broker quotes. The fair value and carrying value of the Company's long-term debt was $5.6 billion and $5.8 billion, respectively, as of April 1, 2023. The fair value and carrying value of the Company's long-term debt was $5.1 billion and $5.3 billion, respectively, as of December 31, 2022. Counterparty credit risk concentration and collateral requirements The Company is exposed to credit loss in the event of nonperformance by counterparties on derivative financial and commodity contracts. Management believes a concentration of credit risk with respect to derivative counterparties is limited due to the credit ratings and use of master netting and reciprocal collateralization agreements with the counterparties and the use of exchange-traded commodity contracts. Master netting agreements apply in situations where the Company executes multiple contracts with the same counterparty. Certain counterparties represent a concentration of credit risk to the Company. If those counterparties fail to perform according to the terms of derivative contracts, this would result in a loss to the Company of approximately $20 million, net of collateral already received from those counterparties, as of April 1, 2023. For certain derivative contracts, reciprocal collateralization agreements with counterparties call for the posting of collateral in the form of cash, treasury securities or letters of credit if a fair value loss position to the Company or its counterparties exceeds a certain amount. In addition, the Company is required to maintain cash margin accounts in connection with its open positions for exchange-traded commodity derivative instruments executed with the counterparty that are subject to enforceable netting agreements. As of April 1, 2023, the Company posted $25 million in margin deposits for exchange-traded commodity derivative instruments, which was reflected as an increase in accounts receivable, net on the Consolidated Balance Sheet. Management believes concentrations of credit risk with respect to accounts receivable is limited due to the generally high credit quality of the Company’s major customers, as well as the large number and geographic dispersion of smaller customers. |
Reportable Segments
Reportable Segments | 3 Months Ended |
Apr. 01, 2023 | |
Segment Reporting [Abstract] | |
Reportable Segments | Reportable segments Kellogg Company is a leading producer of snacks, cereal, and frozen foods. It is the second largest producer of crackers, a leading producer of savory snacks, and the world's leading producer of cereal. Additional product offerings include toaster pastries, cereal bars, veggie foods and noodles. Kellogg products are manufactured and marketed globally. Principal markets for these products include the United States, United Kingdom, Nigeria, Canada, Mexico, and Australia. The Company manages its operations through four operating segments that are based on geographic location – North America which includes U.S. businesses and Canada; Europe which consists of European countries; Latin America which consists of Central and South America and includes Mexico; and AMEA (Asia Middle East Africa) which consists of Africa, Middle East, Australia and other Asian and Pacific markets. These operating segments also represent our reportable segments. Corporate includes corporate administration and initiatives as well as share-based compensation. The measurement of reportable segment results is based on segment operating profit which is generally consistent with the presentation of operating profit in the Consolidated Statement of Income. Reportable segment results were as follows: Quarter ended (millions) April 1, April 2, Net sales North America $ 2,388 $ 2,110 Europe 604 589 Latin America 292 256 AMEA 770 718 Total Reportable Segments 4,054 3,673 Corporate (1) (1) Consolidated $ 4,053 $ 3,672 Operating profit North America $ 366 $ 339 Europe 92 98 Latin America 25 14 AMEA 74 66 Total Reportable Segments 557 517 Corporate (117) — Consolidated $ 440 $ 517 Supplemental product information is provided below for net sales to external customers: Quarter ended (millions) April 1, April 2, Snacks $ 2,022 $ 1,775 Cereal 1,390 1,281 Frozen 292 291 Noodles and other 349 325 Consolidated $ 4,053 $ 3,672 |
Supplemental Financial Statemen
Supplemental Financial Statement Data | 3 Months Ended |
Apr. 01, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Supplemental Balance Sheet Disclosures | Supplemental Financial Statement Data Consolidated Balance Sheet (millions) April 1, 2023 (unaudited) December 31, 2022 Trade receivables $ 1,577 $ 1,449 Allowance for credit losses (20) (13) Refundable income taxes 31 82 Other receivables 232 218 Accounts receivable, net $ 1,820 $ 1,736 Raw materials and supplies $ 443 $ 426 Finished goods and materials in process 1,358 1,342 Inventories $ 1,801 $ 1,768 Intangible assets not subject to amortization $ 1,975 $ 1,969 Intangible assets subject to amortization, net 322 327 Other intangibles, net $ 2,297 $ 2,296 |
Accounting Policies (Policies)
Accounting Policies (Policies) | 3 Months Ended |
Apr. 01, 2023 | |
Accounting Policies [Abstract] | |
Basis of presentation | Basis of presentation The unaudited interim financial information of Kellogg Company (the Company) included in this report reflects all adjustments, all of which are of a normal and recurring nature, that management believes are necessary for a fair statement of the results of operations, comprehensive income, financial position, equity and cash flows for the periods presented. This interim information should be read in conjunction with the financial statements and accompanying footnotes within the Company’s 2022 Annual Report on Form 10-K. The condensed balance sheet information at December 31, 2022 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. The results of operations for the quarter ended April 1, 2023 are not necessarily indicative of the results to be expected for other interim periods or the full year. |
Accounts payable - Supplier Finance Programs | Accounts payable - Supplier Finance Programs The Company establishes competitive market-based terms with our suppliers, regardless of whether they participate in supplier finance programs, which generally range from 0 to 150 days dependent on their respective industry and geography. |
Accounting standards adopted in the period | Accounting standards adopted in the period Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations. In September 2022, the FASB issued an ASU to improve the disclosures of supplier finance programs. Specifically, the ASU requires disclosure of key terms of the supplier finance programs and a rollforward of the related obligations. The amendments in this ASU do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2022, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company has historically presented information regarding the nature and amount of outstanding Accounts Payable obligations confirmed into supplier finance programs within the Accounting Policies note of the financial statements. The Company adopted the ASU in the first quarter of 2023 and plans to include the rollforward information in the first quarter of 2024. |
Equity (Tables)
Equity (Tables) | 3 Months Ended |
Apr. 01, 2023 | |
Equity [Abstract] | |
Summary of Accumulated Other Comprehensive Income (Loss) | Accumulated other comprehensive income (loss), net of tax, as of April 1, 2023 and December 31, 2022 consisted of the following: (millions) April 1, December 31, Foreign currency translation adjustments $ (2,063) $ (2,111) Net investment hedges gain (loss) 240 282 Cash flow hedges — net deferred gain (loss) 139 150 Postretirement and postemployment benefits: Net experience gain (loss) 1 2 Prior service credit (cost) (27) (27) Available-for-sale securities unrealized net gain (loss) (3) (4) Total accumulated other comprehensive income (loss) $ (1,713) $ (1,708) |
Employee Benefits (Tables)
Employee Benefits (Tables) | 3 Months Ended |
Apr. 01, 2023 | |
Retirement Benefits [Abstract] | |
Components of Plan Benefit Expense | Pension Quarter ended (millions) April 1, 2023 April 2, 2022 Service cost $ 6 $ 9 Interest cost 44 29 Expected return on plan assets (53) (71) Amortization of unrecognized prior service cost 2 2 Recognized net gain — (21) Total pension income $ (1) $ (52) Other nonpension postretirement Quarter ended (millions) April 1, 2023 April 2, 2022 Service cost $ 2 $ 3 Interest cost 10 6 Expected return on plan assets (24) (28) Amortization of unrecognized prior service cost (2) (2) Total postretirement benefit income $ (14) $ (21) Postemployment Quarter ended (millions) April 1, 2023 April 2, 2022 Service cost $ 1 $ 1 Recognized net experience gain (1) (1) Total postemployment expense $ — $ — |
Contributions to Employee Benefit Plans | Company contributions to employee benefit plans are summarized as follows: (millions) Pension Nonpension postretirement Total Quarter ended: April 1, 2023 $ — $ 5 $ 5 April 2, 2022 $ 1 $ 6 $ 7 Full year: Fiscal year 2023 (projected) $ 5 $ 21 $ 26 Fiscal year 2022 (actual) $ 3 $ 20 $ 23 |
Derivative Instruments and Fa_2
Derivative Instruments and Fair Value Measurements (Tables) | 3 Months Ended |
Apr. 01, 2023 | |
Derivative Instruments and Fair Value Measurements [Abstract] | |
Schedule of Total Notional Amounts of Derivative Instruments | Total notional amounts of the Company’s derivative instruments as of April 1, 2023 and December 31, 2022 were as follows: (millions) April 1, December 31, Foreign currency exchange contracts $ 2,957 $ 2,502 Cross-currency contracts 2,101 1,983 Interest rate contracts 2,275 2,657 Commodity contracts 456 230 Total $ 7,789 $ 7,372 |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | The following table presents assets and liabilities that were measured at fair value in the Consolidated Balance Sheet on a recurring basis as of April 1, 2023 and December 31, 2022: Derivatives designated as hedging instruments April 1, 2023 December 31, 2022 (millions) Level 1 Level 2 Total Level 1 Level 2 Total Assets: Cross-currency contracts: Other current assets $ — $ 63 $ 63 $ — $ 88 $ 88 Other assets — 26 26 — 36 36 Interest rate contracts: Other current assets — — — — 45 45 Other assets — 10 10 — 25 25 Total assets $ — $ 99 $ 99 $ — $ 194 $ 194 Liabilities: Cross-currency contracts: Other current liabilities $ — $ (7) $ (7) $ — $ — $ — Other liabilities — — — — — — Interest rate contracts(a): Other current liabilities — — — — — — Other liabilities — (77) (77) — (86) (86) Total liabilities $ — $ (84) $ (84) $ — $ (86) $ (86) (a) The fair value of the related hedged portion of the Company's long-term debt, a level 2 liability, was $1.1 billion as of April 1, 2023 and December 31, 2022, respectively. Derivatives not designated as hedging instruments April 1, 2023 December 31, 2022 (millions) Level 1 Level 2 Total Level 1 Level 2 Total Assets: Foreign currency exchange contracts: Other current assets $ — $ 58 $ 58 $ — $ 74 $ 74 Other assets — 14 14 — 14 14 Interest rate contracts: Other current assets — 9 9 — 4 4 Other assets — 6 6 — 14 14 Commodity contracts: Other current assets 6 — 6 4 — 4 Total assets $ 6 $ 87 $ 93 $ 4 $ 106 $ 110 Liabilities: Foreign currency exchange contracts: Other current liabilities $ — $ (45) $ (45) $ — $ (50) $ (50) Other liabilities — (11) (11) — (9) (9) Interest rate contracts: Other current liabilities — (11) (11) — (7) (7) Other liabilities — (9) (9) — (18) (18) Commodity contracts: Other current liabilities (6) — (6) (2) — (2) Total liabilities $ (6) $ (76) $ (82) $ (2) $ (84) $ (86) |
Schedule of Derivative Instruments in Statement of Financial Position Fair Value | The following amounts were recorded on the Consolidated Balance Sheet related to cumulative basis adjustments for existing fair value hedges as of April 1, 2023 and December 31, 2022. (millions) Line Item in the Consolidated Balance Sheet in which the hedged item is included Carrying amount of the hedged liabilities Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged liabilities (a) April 1, December 31, April 1, December 31, Interest rate contracts Current maturities of long-term debt $ 273 $ 483 $ (2) $ (3) Interest rate contracts Long-term debt $ 2,288 $ 2,250 $ (63) $ (74) (a) The fair value adjustment related to current maturities of long-term debt includes ($2) million and ($3) million from discontinued hedging relationships as of April 1, 2023 and December 31, 2022, respectively. The fair value adjustment related to long-term debt includes $11 million and $13 million from discontinued hedging relationships as of April 1, 2023 and December 31, 2022, respectively. |
Schedule of Offsetting Assets | As of April 1, 2023: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 192 $ (135) $ (1) $ 56 Total liability derivatives $ (166) $ 135 $ 31 $ — As of December 31, 2022: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 304 $ (153) $ (33) $ 118 Total liability derivatives $ (172) $ 153 $ 19 $ — |
Schedule of Offsetting Liabilities | As of April 1, 2023: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 192 $ (135) $ (1) $ 56 Total liability derivatives $ (166) $ 135 $ 31 $ — As of December 31, 2022: Gross Amounts Not Offset in the Amounts Financial Cash Collateral Net Total asset derivatives $ 304 $ (153) $ (33) $ 118 Total liability derivatives $ (172) $ 153 $ 19 $ — |
Schedule of the Effect of Derivative Instruments on the Consolidated Statements of Income and Comprehensive Income | The effect of derivative instruments on the Consolidated Statements of Income and Comprehensive Income for the quarters ended April 1, 2023 and April 2, 2022 was as follows: Derivatives and non-derivatives in net investment hedging relationships (millions) Gain (loss) Gain (loss) excluded from assessment of hedge effectiveness Location of gain (loss) in income of excluded component April 1, April 2, April 1, April 2, Foreign currency denominated long-term debt $ (32) $ 68 $ — $ — Cross-currency contracts (25) 33 14 6 Interest expense Total $ (57) $ 101 $ 14 $ 6 Derivatives not designated as hedging instruments (millions) Location of gain Gain (loss) April 1, April 2, Foreign currency exchange contracts COGS $ (6) $ (12) Foreign currency exchange contracts Other income (expense), net (4) (2) Foreign currency exchange contracts SG&A (2) 1 Interest rate contracts Interest expense — 1 Commodity contracts COGS (39) 112 Total $ (51) $ 100 The effect of fair value and cash flow hedge accounting on the Consolidated Income Statement for the quarters ended April 1, 2023 and April 2, 2022: April 1, 2023 April 2, 2022 (millions) Interest Expense Interest Expense Total amounts of income and expense line items presented in the Consolidated Income Statement in which the effects of fair value or cash flow hedges are recorded $ 80 $ 56 Gain (loss) on fair value hedging relationships: Interest contracts: Hedged items (12) 41 Derivatives designated as hedging instruments 13 (40) Gain (loss) on cash flow hedging relationships: Interest contracts: Amount of gain (loss) reclassified from AOCI into income (3) (4) |
Schedule of Available-for-sale Securities Reconciliation | April 1, 2023 December 31, 2022 Unrealized Unrealized (millions) Cost Gain (Loss) Market Value Cost Gain (Loss) Market Value Corporate bonds $ 52 $ (4) $ 48 $ 52 $ (5) $ 47 |
Reportable Segments (Tables)
Reportable Segments (Tables) | 3 Months Ended |
Apr. 01, 2023 | |
Segment Reporting [Abstract] | |
Schedule of Reportable Segment Information | Reportable segment results were as follows: Quarter ended (millions) April 1, April 2, Net sales North America $ 2,388 $ 2,110 Europe 604 589 Latin America 292 256 AMEA 770 718 Total Reportable Segments 4,054 3,673 Corporate (1) (1) Consolidated $ 4,053 $ 3,672 Operating profit North America $ 366 $ 339 Europe 92 98 Latin America 25 14 AMEA 74 66 Total Reportable Segments 557 517 Corporate (117) — Consolidated $ 440 $ 517 |
Revenue from External Customers by Products and Services | Supplemental product information is provided below for net sales to external customers: Quarter ended (millions) April 1, April 2, Snacks $ 2,022 $ 1,775 Cereal 1,390 1,281 Frozen 292 291 Noodles and other 349 325 Consolidated $ 4,053 $ 3,672 |
Supplemental Financial Statem_2
Supplemental Financial Statement Data (Tables) | 3 Months Ended |
Apr. 01, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Supplemental Financial Data Consolidated Balance Sheet [Table Text Block] | Consolidated Balance Sheet (millions) April 1, 2023 (unaudited) December 31, 2022 Trade receivables $ 1,577 $ 1,449 Allowance for credit losses (20) (13) Refundable income taxes 31 82 Other receivables 232 218 Accounts receivable, net $ 1,820 $ 1,736 Raw materials and supplies $ 443 $ 426 Finished goods and materials in process 1,358 1,342 Inventories $ 1,801 $ 1,768 Intangible assets not subject to amortization $ 1,975 $ 1,969 Intangible assets subject to amortization, net 322 327 Other intangibles, net $ 2,297 $ 2,296 |
Accounting Policies - Narrative
Accounting Policies - Narrative (Details) - USD ($) $ in Millions | Apr. 01, 2023 | Dec. 31, 2022 |
Accounting Policies [Abstract] | ||
Obligations placed in accounts payable tracking system | $ 1,100 | $ 1,100 |
Minimum [Member] | ||
Supplier finance program general payment timing, period | 0 days | |
Maximum [Member] | ||
Supplier finance program general payment timing, period | 150 days |
Proposed separation transacti_2
Proposed separation transaction (Details) $ in Millions | 3 Months Ended |
Apr. 01, 2023 USD ($) | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Proposed separation transaction related costs | $ 51 |
COGS | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Proposed separation transaction related costs | 4 |
Selling, General and Administrative Expenses | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Proposed separation transaction related costs | $ 47 |
Sale of Accounts Receivable - N
Sale of Accounts Receivable - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Apr. 01, 2023 | Apr. 02, 2022 | Dec. 31, 2022 | |
Monetization Program | Other income (expense) | |||
Transfer of Financial Assets Accounted for as Sales [Line Items] | |||
Gain (Loss) on Sale of Accounts Receivable | $ (12) | $ (2) | |
Monetization Program | Maximum [Member] | |||
Transfer of Financial Assets Accounted for as Sales [Line Items] | |||
Transfers of Accounts Receivable Agreements | 945 | $ 920 | |
Monetization Program | Sold And Outstanding | |||
Transfer of Financial Assets Accounted for as Sales [Line Items] | |||
Transfer of Financial Assets Accounted for as Sales, Amount Derecognized | 911 | 865 | |
Kellogg Foreign Subsidiaries Other Program | |||
Transfer of Financial Assets Accounted for as Sales [Line Items] | |||
Transfers of Accounts Receivable Agreements | $ 28 | $ 31 |
Divestiture - Narrative (Detail
Divestiture - Narrative (Details) - RUSSIAN FEDERATION - Europe $ in Millions | 3 Months Ended |
Apr. 01, 2023 USD ($) | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |
Assets as a percentage of total company assets | 1% |
Sales as a percentage of consolidated net sales | 1% |
Net book value | $ 70 |
CTA | $ (95) |
Equity - Narrative (Details)
Equity - Narrative (Details) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | ||
Apr. 01, 2023 | Apr. 02, 2022 | Feb. 29, 2020 | |
Equity, Class of Treasury Stock [Line Items] | |||
Anti-dilutive potential common shares excluded from reconciliation | 4 | 8 | |
Common stock repurchased | $ 300 | ||
February 2020 Share Repurchase Program | |||
Equity, Class of Treasury Stock [Line Items] | |||
Common stock repurchased (in shares) | 5 | ||
Common stock repurchased | $ 300 | ||
December 2022 Share Repurchase Program | |||
Equity, Class of Treasury Stock [Line Items] | |||
Stock repurchase program, authorized amount | $ 1,500 |
Equity - Summary of Accumulated
Equity - Summary of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions | Apr. 01, 2023 | Dec. 31, 2022 |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ||
Foreign currency translation adjustments | $ (2,063) | $ (2,111) |
Net investment hedges gain (loss) | 240 | 282 |
Cash flow hedges — net deferred gain (loss) | 139 | 150 |
Postretirement and postemployment benefits: | ||
Net experience gain (loss) | 1 | 2 |
Prior service credit (cost) | (27) | (27) |
Available-for-sale securities unrealized net gain (loss) | (3) | (4) |
Total accumulated other comprehensive income (loss) | $ (1,713) | $ (1,708) |
Long-term debt - Narrative (Det
Long-term debt - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |||
Mar. 01, 2023 | Apr. 01, 2023 | Apr. 02, 2022 | Dec. 31, 2022 | |
Debt Instrument [Line Items] | ||||
Notional amount of derivative | $ 7,789 | $ 7,372 | ||
Unrealized gain (loss) on cash flow hedges, pre-tax | (18) | $ 77 | ||
Cash Flow Hedging | Interest expense | ||||
Debt Instrument [Line Items] | ||||
Unrealized gain (loss) on cash flow hedges, pre-tax | 47 | $ 82 | ||
5.25% 10-year U.S. Dollar Notes Due 2033 | ||||
Debt Instrument [Line Items] | ||||
Debt Instrument, Face Amount | $ 400 | |||
Debt Instrument, Interest Rate, Stated Percentage | 5.25% | |||
Proceeds from Debt, Net of Issuance Costs | $ 396 | |||
Notional amount of derivative | $ 400 | |||
Debt Instrument, Interest Rate, Effective Percentage | 3.06% | |||
5.25% 10-year U.S. Dollar Notes Due 2033 | Cash Flow Hedging | Interest expense | ||||
Debt Instrument [Line Items] | ||||
Unrealized gain (loss) on cash flow hedges, pre-tax | 47 | |||
Cumulative unrealized gain (loss) on cash flow hedge settlement, pre-tax | $ 91 | |||
2.75% 10-year U.S. Dollar Notes Due 2023 | ||||
Debt Instrument [Line Items] | ||||
Debt Instrument, Face Amount | $ 210 | |||
Debt Instrument, Interest Rate, Stated Percentage | 2.75% |
Employee Benefits - Components
Employee Benefits - Components of Plan Benefit Expense (Details) - USD ($) $ in Millions | 3 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | |
Pension | Global Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost | $ 6 | $ 9 |
Interest cost | 44 | 29 |
Expected return on plan assets | (53) | (71) |
Amortization of unrecognized prior service cost (gain) | 2 | 2 |
Recognized net (gain) loss | 0 | (21) |
Net periodic benefit cost | (1) | (52) |
Other Nonpension Postretirement | U.S. and Canada | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost | 2 | 3 |
Interest cost | 10 | 6 |
Expected return on plan assets | (24) | (28) |
Amortization of unrecognized prior service cost (gain) | (2) | (2) |
Total plan benefit (income) expense | (14) | (21) |
Postemployment | Global Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost | 1 | 1 |
Recognized net (gain) loss | (1) | (1) |
Total plan benefit (income) expense | $ 0 | $ 0 |
Employee Benefits - Component_2
Employee Benefits - Components of Plan Benefit Expense Narrative (Details) $ in Millions | 3 Months Ended |
Apr. 02, 2022 USD ($) | |
UNITED STATES | Pension | |
Defined Benefit Plan Disclosure [Line Items] | |
Recognized net (gain) loss | $ 21 |
Employee Benefits - Contributio
Employee Benefits - Contributions to Employee Benefit Plans (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | Jul. 02, 2022 | |
Defined Benefit Plan Disclosure [Line Items] | |||
Employer contributions to employee benefit plans | $ 5 | $ 7 | $ 23 |
Total current year projected employer contributions | 26 | ||
Global Plans | Pension | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Employer contributions to employee benefit plans | 0 | 1 | 3 |
Total current year projected employer contributions | 5 | ||
U.S. and Canada | Nonpension postretirement | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Employer contributions to employee benefit plans | 5 | $ 6 | $ 20 |
Total current year projected employer contributions | $ 21 |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | |
Income Tax Contingency [Line Items] | ||
Effective income tax rate | 22% | 21% |
Income taxes | $ 86 | $ 112 |
Unrecognized tax benefits | 37 | |
Projected additions to unrecognized tax benefits | 3 | |
Unrecognized tax benefits that would affect the effective income tax rate | 30 | |
Income tax related interest accrued | 9 | |
Other current liabilities | ||
Income Tax Contingency [Line Items] | ||
Unrecognized tax benefits | $ 21 |
Derivative Instruments and Fa_3
Derivative Instruments and Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | |
Derivative [Line Items] | ||
Net deferred losses reported in AOCI to be reclassified into income in the next twelve months | $ (10) | |
Collateral posted | 0 | |
Gain (loss) recognized in AOCI | (57) | $ 101 |
Unrealized gain (loss) on cash flow hedges, pre-tax | (18) | 77 |
Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure | 20 | |
Net Investment Hedging | ||
Derivative [Line Items] | ||
Gain (loss) recognized in AOCI | (57) | 101 |
Cross currency interest rate contract | Net Investment Hedging | ||
Derivative [Line Items] | ||
Gain (loss) recognized in AOCI | 17 | 37 |
Accounts Receivable, Net | Exchange-traded commodity | ||
Derivative [Line Items] | ||
Margin deposits | 25 | |
Interest expense | Cash Flow Hedging | ||
Derivative [Line Items] | ||
Unrealized gain (loss) on cash flow hedges, pre-tax | 47 | 82 |
Interest expense | Cross currency interest rate contract | Net Investment Hedging | ||
Derivative [Line Items] | ||
Gain (loss) recognized in AOCI | $ (25) | $ 33 |
Derivative Instruments and Fa_4
Derivative Instruments and Fair Value Measurements - Schedule of Total Notional Amounts of Derivative Instruments (Details) - USD ($) $ in Millions | Apr. 01, 2023 | Dec. 31, 2022 |
Derivatives, Fair Value [Line Items] | ||
Notional amount of derivative | $ 7,789 | $ 7,372 |
Foreign currency exchange contracts | ||
Derivatives, Fair Value [Line Items] | ||
Notional amount of derivative | 2,957 | 2,502 |
Cross currency interest rate contract | ||
Derivatives, Fair Value [Line Items] | ||
Notional amount of derivative | 2,101 | 1,983 |
Interest rate contracts | ||
Derivatives, Fair Value [Line Items] | ||
Notional amount of derivative | 2,275 | 2,657 |
Commodity contracts | ||
Derivatives, Fair Value [Line Items] | ||
Notional amount of derivative | $ 456 | $ 230 |
Derivative Instruments and Fa_5
Derivative Instruments and Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Millions | Apr. 01, 2023 | Dec. 31, 2022 | |
Derivatives, Fair Value [Line Items] | |||
Fair Value Of Related Hedge Portion Of Long Term Debt | $ 1,100 | $ 1,100 | |
Long-term debt total, carrying value | 5,800 | 5,300 | |
Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 99 | 194 | |
Liabilities | (84) | (86) | |
Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 93 | 110 | |
Liabilities | (82) | (86) | |
Level 1 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 0 | |
Liabilities | 0 | 0 | |
Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 6 | 4 | |
Liabilities | (6) | (2) | |
Level 2 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 99 | 194 | |
Liabilities | (84) | (86) | |
Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 87 | 106 | |
Liabilities | (76) | (84) | |
Cross currency interest rate contract | Other current assets | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 63 | 88 | |
Cross currency interest rate contract | Other current assets | Level 1 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 0 | |
Cross currency interest rate contract | Other current assets | Level 2 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 63 | 88 | |
Cross currency interest rate contract | Other assets | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 26 | 36 | |
Cross currency interest rate contract | Other assets | Level 1 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 0 | |
Cross currency interest rate contract | Other assets | Level 2 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 26 | 36 | |
Cross currency interest rate contract | Other current liabilities | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (7) | 0 | |
Cross currency interest rate contract | Other current liabilities | Level 1 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Cross currency interest rate contract | Other current liabilities | Level 2 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (7) | 0 | |
Cross currency interest rate contract | Other liabilities | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Cross currency interest rate contract | Other liabilities | Level 1 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Cross currency interest rate contract | Other liabilities | Level 2 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Foreign currency exchange contracts | Other current assets | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 58 | 74 | |
Foreign currency exchange contracts | Other current assets | Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 0 | |
Foreign currency exchange contracts | Other current assets | Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 58 | 74 | |
Foreign currency exchange contracts | Other assets | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 14 | 14 | |
Foreign currency exchange contracts | Other assets | Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 0 | |
Foreign currency exchange contracts | Other assets | Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 14 | 14 | |
Foreign currency exchange contracts | Other current liabilities | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (45) | (50) | |
Foreign currency exchange contracts | Other current liabilities | Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Foreign currency exchange contracts | Other current liabilities | Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (45) | (50) | |
Foreign currency exchange contracts | Other liabilities | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (11) | (9) | |
Foreign currency exchange contracts | Other liabilities | Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Foreign currency exchange contracts | Other liabilities | Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (11) | (9) | |
Interest rate contracts | Other current assets | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 45 | |
Interest rate contracts | Other current assets | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 9 | 4 | |
Interest rate contracts | Other current assets | Level 1 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 0 | |
Interest rate contracts | Other current assets | Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 0 | |
Interest rate contracts | Other current assets | Level 2 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 45 | |
Interest rate contracts | Other current assets | Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 9 | 4 | |
Interest rate contracts | Other assets | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 10 | 25 | |
Interest rate contracts | Other assets | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 6 | 14 | |
Interest rate contracts | Other assets | Level 1 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 0 | |
Interest rate contracts | Other assets | Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 0 | |
Interest rate contracts | Other assets | Level 2 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 10 | 25 | |
Interest rate contracts | Other assets | Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 6 | 14 | |
Interest rate contracts | Other current liabilities | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Interest rate contracts | Other current liabilities | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (11) | (7) | |
Interest rate contracts | Other current liabilities | Level 1 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Interest rate contracts | Other current liabilities | Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Interest rate contracts | Other current liabilities | Level 2 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | [1] | 0 | 0 |
Interest rate contracts | Other current liabilities | Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (11) | (7) | |
Interest rate contracts | Other liabilities | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (77) | (86) | |
Interest rate contracts | Other liabilities | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (9) | (18) | |
Interest rate contracts | Other liabilities | Level 1 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Interest rate contracts | Other liabilities | Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Interest rate contracts | Other liabilities | Level 2 | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | [1] | (77) | (86) |
Interest rate contracts | Other liabilities | Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (9) | (18) | |
Commodity contracts | Other current assets | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 6 | 4 | |
Commodity contracts | Other current assets | Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 6 | 4 | |
Commodity contracts | Other current assets | Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Assets | 0 | 0 | |
Commodity contracts | Other current liabilities | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (6) | (2) | |
Commodity contracts | Other current liabilities | Level 1 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | (6) | (2) | |
Commodity contracts | Other current liabilities | Level 2 | Not Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Liabilities | 0 | 0 | |
Net Investment Hedging | |||
Derivatives, Fair Value [Line Items] | |||
Long-term debt total, carrying value | $ 1,600 | $ 1,600 | |
[1]The fair value of the related hedged portion of the Company's long-term debt, a level 2 liability, was $1.1 billion as of April 1, 2023 and December 31, 2022, respectively. |
Derivative Instruments and Fa_6
Derivative Instruments and Fair Value Measurements - Schedule of Cumulative Basis Adjustments for Fair Value Hedges (Details) - USD ($) $ in Millions | Apr. 01, 2023 | Dec. 31, 2022 | |
Derivatives, Fair Value [Line Items] | |||
Current maturities of long-term debt | $ 567 | $ 780 | |
Long-term debt | 5,759 | 5,317 | |
Carrying amount of hedged liability | Fair Value Hedges | Interest rate contracts | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Current maturities of long-term debt | 273 | 483 | |
Long-term debt | 2,288 | 2,250 | |
Cumulative fair value adjustment | Fair Value Hedges | Interest rate contracts | Designated as Hedging Instrument | |||
Derivatives, Fair Value [Line Items] | |||
Current maturities of long-term debt | [1] | (2) | (3) |
Long-term debt | [1] | (63) | (74) |
Hedging adjustment | Discontinued Hedges | Interest rate contracts | |||
Derivatives, Fair Value [Line Items] | |||
Current maturities of long-term debt | (2) | (3) | |
Long-term debt | $ 11 | $ 13 | |
[1]The fair value adjustment related to current maturities of long-term debt includes ($2) million and ($3) million from discontinued hedging relationships as of April 1, 2023 and December 31, 2022, respectively. The fair value adjustment related to long-term debt includes $11 million and $13 million from discontinued hedging relationships as of April 1, 2023 and December 31, 2022, respectively. |
Derivative Instruments and Fa_7
Derivative Instruments and Fair Value Measurements - Schedule of Offsetting Assets and Liabilities (Details) - USD ($) $ in Millions | Apr. 01, 2023 | Dec. 31, 2022 |
Offsetting [Abstract] | ||
Asset derivatives, Amounts Presented in the Consolidated Balance Sheet | $ 192 | $ 304 |
Asset derivatives, Financial Instruments, Gross Amounts Not Offset in the Consolidated Balance Sheet | (135) | (153) |
Asset derivatives, Cash Collateral Posted, Gross Amounts Not Offset in the Consolidated Balance Sheet | (1) | (33) |
Asset derivatives, Net Amount | 56 | 118 |
Liability derivatives, Amounts Presented in the Consolidated Balance Sheet | (166) | (172) |
Liability derivatives, Financial Instruments, Gross Amounts Not Offset in the Consolidated Balance Sheet | 135 | 153 |
Liability derivatives, Cash Collateral Received, Gross Amounts Not Offset in the Consolidated Balance Sheet | 31 | 19 |
Liability derivatives, net amount | $ 0 | $ 0 |
Derivative Instruments and Fa_8
Derivative Instruments and Fair Value Measurements - Effect of Derivative Instruments on the Consolidated Statements of Income and Comprehensive Income (Details) - USD ($) $ in Millions | 3 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in AOCI | $ (57) | $ 101 |
Not Designated as Hedging Instrument | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in income | (51) | 100 |
Not Designated as Hedging Instrument | Foreign currency exchange contracts | COGS | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in income | (6) | (12) |
Not Designated as Hedging Instrument | Foreign currency exchange contracts | Selling, General and Administrative Expenses | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in income | (2) | 1 |
Not Designated as Hedging Instrument | Foreign currency exchange contracts | Interest expense | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in income | 0 | 1 |
Not Designated as Hedging Instrument | Foreign currency exchange contracts | Other income (expense), net | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in income | (4) | (2) |
Not Designated as Hedging Instrument | Commodity contracts | COGS | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in income | (39) | 112 |
Net Investment Hedging | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in AOCI | (57) | 101 |
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net | 14 | 6 |
Net Investment Hedging | Foreign currency denominated long-term debt | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in AOCI | (32) | 68 |
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net | 0 | 0 |
Net Investment Hedging | Cross currency interest rate contract | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in AOCI | 17 | 37 |
Net Investment Hedging | Cross currency interest rate contract | Interest expense | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) recognized in AOCI | (25) | 33 |
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net | $ 14 | $ 6 |
Derivative Instruments and Fa_9
Derivative Instruments and Fair Value Measurements - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on Consolidated Statement of Income (Details) - USD ($) $ in Millions | 3 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||
Interest Expense, Debt | $ 80 | $ 56 |
Interest rate contracts | Designated as Hedging Instrument | Cash Flow Hedging | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Gain (loss) reclassified from AOCI into income | (3) | (4) |
Interest rate contracts | Interest expense | Designated as Hedging Instrument | Fair Value Hedges | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Hedged items | (12) | 41 |
Derivatives designated as hedging instruments | $ 13 | $ (40) |
Derivative Instruments and F_10
Derivative Instruments and Fair Value Measurements - Schedule of Other Fair Value Measurements (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | Dec. 31, 2022 | |
Debt Securities, Available-for-sale [Line Items] | |||
Sales of available for sale securities | $ 5 | $ 1 | |
Purchases of available for sale securities | 5 | 2 | |
Corporate bonds | |||
Debt Securities, Available-for-sale [Line Items] | |||
Available-for-sale securities, amortized cost | 52 | $ 52 | |
Available-for-sale securities, unrealized gain (loss) | (4) | (5) | |
Available-for-sale securities, market value | 48 | $ 47 | |
Level 2 | Corporate bonds | |||
Debt Securities, Available-for-sale [Line Items] | |||
Sales of available for sale securities | 5 | 1 | |
Purchases of available for sale securities | $ 5 | $ 2 |
Derivative Instruments and F_11
Derivative Instruments and Fair Value Measurements - Equity Investments (Details) - USD ($) $ in Millions | Apr. 01, 2023 | Dec. 31, 2022 |
Other assets | Level 2 | ||
Derivatives, Fair Value [Line Items] | ||
Equity investments | $ 40 | $ 40 |
Derivative Instruments and F_12
Derivative Instruments and Fair Value Measurements - Schedule of Fair Value of Long-term Debt (Details) - USD ($) $ in Billions | Apr. 01, 2023 | Dec. 31, 2022 |
Derivative Instruments and Fair Value Measurements [Abstract] | ||
Long-term debt, fair value | $ 5.6 | $ 5.1 |
Long-term debt total, carrying value | $ 5.8 | $ 5.3 |
Reportable Segments (Details)
Reportable Segments (Details) $ in Millions | 3 Months Ended | |
Apr. 01, 2023 USD ($) | Apr. 02, 2022 USD ($) | |
Segment Reporting Information [Line Items] | ||
Number of operating segments | 4 | |
Net sales | $ 4,053 | $ 3,672 |
Operating profit | 440 | 517 |
Operating Segments | ||
Segment Reporting Information [Line Items] | ||
Net sales | 4,054 | 3,673 |
Operating profit | 557 | 517 |
Operating Segments | North America | ||
Segment Reporting Information [Line Items] | ||
Net sales | 2,388 | 2,110 |
Operating profit | 366 | 339 |
Operating Segments | Europe | ||
Segment Reporting Information [Line Items] | ||
Net sales | 604 | 589 |
Operating profit | 92 | 98 |
Operating Segments | Latin America | ||
Segment Reporting Information [Line Items] | ||
Net sales | 292 | 256 |
Operating profit | 25 | 14 |
Operating Segments | AMEA | ||
Segment Reporting Information [Line Items] | ||
Net sales | 770 | 718 |
Operating profit | 74 | 66 |
Corporate | ||
Segment Reporting Information [Line Items] | ||
Net sales | (1) | (1) |
Operating profit | $ (117) | $ 0 |
Reportable Segments Supplementa
Reportable Segments Supplemental Product Information (Details) - USD ($) $ in Millions | 3 Months Ended | |
Apr. 01, 2023 | Apr. 02, 2022 | |
Segment Reporting Information [Line Items] | ||
Net sales | $ 4,053 | $ 3,672 |
Snacks | ||
Segment Reporting Information [Line Items] | ||
Net sales | 2,022 | 1,775 |
Cereal | ||
Segment Reporting Information [Line Items] | ||
Net sales | 1,390 | 1,281 |
Frozen | ||
Segment Reporting Information [Line Items] | ||
Net sales | 292 | 291 |
Noodles and other | ||
Segment Reporting Information [Line Items] | ||
Net sales | $ 349 | $ 325 |
Supplemental Financial Statem_3
Supplemental Financial Statement Data - Consolidated Balance Sheet (Unaudited) (Details) - USD ($) $ in Millions | Apr. 01, 2023 | Dec. 31, 2022 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Trade receivables | $ 1,577 | $ 1,449 |
Allowance for credit losses | (20) | (13) |
Refundable income taxes | 31 | 82 |
Other receivables | 232 | 218 |
Accounts receivable, net | 1,820 | 1,736 |
Raw materials and supplies | 443 | 426 |
Finished goods and materials in process | 1,358 | 1,342 |
Inventories | 1,801 | 1,768 |
Intangible assets not subject to amortization | 1,975 | 1,969 |
Intangible assets subject to amortization, net | 322 | 327 |
Other intangibles, net | $ 2,297 | $ 2,296 |